Evaluation of Skin Quality Improvement

Completed · Phase 2

Conditions studied: Skin Quality

In brief

The purpose of this study is to comprehensively investigate and objectively demonstrate the effectiveness of hyperdiltue Botox® Cosmetic in improving overall skin quality, more specifically evenness of skin tone, reduction of pore size and improvement in the appearance of preexisting skin scars.

Key facts

Study ID

NCT03097835

Run by

Steve Yoelin M.D. Medical Associates, Inc.

People needed

15

Starts

2018-02-12

Expected to finish

2018-07-26

Last updated by the study team

2019-02-22

Who can join

Age: 35 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ability to follow study instructions and likely to complete all required visits
• Written consent has been obtained
• Written authorization for "Use and Release of Health and Research Study Information" has been obtained
• Subjects who are Fitzpatrick Skin Types II-IV

You may not qualify if…

• Subjects must be Onabotulinum Toxin Type A naive; if subject has had Onabotulinum Toxin Type A administered in the face in the previous 12 months they are excluded
• Subjects must be dermal filler naïve in the lateral canthal region and midface regions
• Subjects must be energy or light device naïve
• Subjects must have average or below-average lifetime sun exposure
• Subjects must be free of inflammatory skin disease(s)

Where it is running

• Steve Yoelin MD & Associates — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.